Login to Your Account

Carsgen's China-led series A to fund clinical trials of CAR-T candidate

By Cornelia Zou
Staff Writer

Monday, December 1, 2014

Carsgen, a Chinese developer of cancer therapies, announced its completion of an undisclosed series A financing led by China-based health care private equity fund BVCF Management Ltd. The proceeds will initiate the clinical trials of Carsgen's lead therapeutic.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription